Close Menu
Home › Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage

Aug 01, 2019
|
staff reporter

This story has been updated with additional details from UnitedHealthcare's coverage policy.

NEW YORK – UnitedHealthcare has issued a positive coverage decision for Myriad Genetics' GeneSight Psychotropic pharmacogenetic test, Myriad disclosed in a filing with the US Securities and Exchange Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

  2. Yourgene Health H1 2019 Revenues Double

  3. Avellino Labs Gets CLIA Certification

  4. Novigenix, RadioMedix to Develop Neuroendocrine Cancer MDx

  5. Bio-Techne Receives Medicare Coverage for Prostate Cancer Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.